I'rom Group Co Ltd (2372.T)
16 Mar 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|56||2012||President, President of Subsidiary, Representative Director|
|2016||Vice President, Director|
|44||2011||Managing Executive Officer, Director of Business Planning|
- BRIEF- I'rom Group unit ID Pharma signs iPS cell generation technology licensing agreement with U.S.-based QurAlis
- BRIEF-I'rom Group to set up unit in Hong Kong to management and support co's business in China
- BRIEF-I'rom Group unit signs iPS cell tech related license agreement with Q-State Biosciences
- BRIEF-I'rom Group says business and capital alliance with OKWAVE unit